3 research outputs found
Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring
Renin-angiotensin-aldosterone system (RAAS) inhibitors are associated with hyperkalemia, but there is little evidence demonstrating patients who receive potassium monitoring have a lower rate of hyperkalemia